Trial Profile
Clinical trial-Efficacy and safety of TAZ/PIPC in elderly respiratory tract infection-NHCAP-
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 29 Jul 2011
Price :
$35
*
At a glance
- Drugs Piperacillin/tazobactam (Primary)
- Indications Bacterial infections; Community-acquired pneumonia; Respiratory tract infections
- Focus Therapeutic Use
- 29 Jul 2011 New trial record